Depression: What we can learn from postmortem studies

Neuroscientist

Volumn 9, Issue 4, 2003, Pages 273-284

  Rajkowska, Grazyna ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Frontal cortex; Mood disorders; Morphometry

Indexed keywords

ANTIDEPRESSANT AGENT; MOOD STABILIZER; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

AUTOPSY; BIPOLAR DEPRESSION; CELL COUNT; CELL DENSITY; CELL LOSS; CELL SIZE; DEPRESSION; DISEASE COURSE; FRONTAL CORTEX; GENE ISOLATION; GLIA; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; MORPHOMETRICS; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW;

AUTOPSY; BRAIN; CELL COUNT; DEPRESSION; NEUROGLIA; NEURONS;

EID: 0042808739     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/1073858403252773     Document Type: Review

References (60)

1. Arango V, Underwoood MD, Gubbi AV, Mann JJ. 1995. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:121-33.
2. Austin M, Whitehead R, Edgar C, Janosky J, Lewis D. 2002. Localized decrease in serotonin transporter-immunoreactive axons in the pre-frontal cortex of depressed subjects committing suicide. Neuroscience 114:807.
3. Bowley MP, Drevets WC, Ongur D, Price JL. 2002. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry 52:404-12.
4. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, and others. 2002. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 51:273-9.
5. Chang A, Li PP, Warsh JJ. 2002. cAMP signal transduction abnormalities in the pathophysiology of mood disorders: contributions from postmortem brain studies. In: Agam G, Everall IP, Belmaker RH, editors. The postmortem brain in psychiatric research. Boston: Kluwer Academic.
6. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT. 2001. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50:260-5.
7. Costello E, Pine D, Hammen C, March J, Plotsky P, Weissman M, and others. 2002. Development and natural history of mood disorders. Biol Psychiatry 52:529.
8. Cotter D, Landau S, Beasley C, Stevenson R, Chana G, MacMillan L, and others. 2002a. The density and spatial distribution of gabaergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 51:377-86.
9. Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. 2002b. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 12:386-94.
10. Cotter D, Mackay D, Landau S, Kerwin R, Everall I. 2001. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Arch Gen Psychiatry 58:545-53.
11. Cotter DR, Pariante CM, Rajkowska G. 2002c. Glial pathology in major psychiatric disorders. In: Agam G, Everall IP, Belmaker RH, editors. The postmortem brain in psychiatric research. Boston: Kluwer Academic. p 49-73.
12. Davidson R, Lewis D, Alloy L, Amaral D, Bush G, Cohen J, and others. 2002. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry 52:478.
13. Dowlatshahi D, MacQueen GM, Wang JF, Reiach JS, Young LT. 1999. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death. J Neurochem 73:1121-6.
14. Drevets W, Price J, Simpson JRJ, Todd R, Reich T, Vannier M, and others. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-7.
15. Duman RS, Malberg J, Nakagawa S, D'Sa C. 2000. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48:732-9.
16. Eastwood SL, Harrison PJ. 2000. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol Psychiatry 5:425-32.
17. Evans S, Akil H, Choudary P, Vawter M, Tomita H, Li J, and others. 2002. Microarray studies in mood disorders: distinct patterns seen between major depression and bipolar disorder in two frontal cortical regions. ACNP 41st Annual Meeting, December 8-12, San Juan, Puerto Rico. Scienfific Abstract. p 36.
18. Guidotti A, Auta J, Davis JM, DiGiorgi Gerevini V, Dwivedi Y, Grayson DR, and others. 2000. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57:1061-9.
19. Hansson E, Muyderman H, Leonova J, Allansson L, Sinclair J, Blomstrand F, and others. 2000. Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochem Int 37:317-29.
20. Hasin DS, Grant BF. 2002. Major depression in 6050 former drinkers: association with past alcohol dependence. Arch Gen Psychiatry 59:794-800.
21. Hedreen JC, Peyser CE, Folstein SE, Ross CA. 1991. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci Lett 133:257-61.
22. Honer WG. 2002. Indications of abnormal connectivity in neuropsychiatric disorders in postmortem studies. In: Agam G, Everall IP, Belmaker RH, editors. The postmortem brain in psychiatric research. Boston: Kluwer Academic. p 75-91.
23. Jakab RL, Goldman-Rakic PS. 2000. Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex. J Comp Neurol 417:337-48.
24. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, Torrey EF, and others. 2000. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5:142-9.
25. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, and others. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood- stabilizing treatments. Mol Psychiatry 7:S71-80.
26. Lewis DA. 1992. The catecholaminergic innervation of primate prefrontal cortex. J Neural Transm Suppl 36:179-200.
27. Lucassen PJ, Muller MB, Holsboer F, Bauer J, Holtrop A, Wouda J, and others. 2001. Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol 158:453-68.
28. Manji HK, Barker JL, Zhang L. 2002. Lithium robustly increases glial proliferation: a therapeutic role in the treatment of severe mood disorders? [CD-ROM]. Program No. 308.14. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience.
29. Manji HK, Drevets WC, Charney DS. 2001. The cellular neurobiology of depression. Nat Med 7:541-7.
30. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, and others. 2000. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-38.
31. Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CA, and others. 2000. Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder. Biol Psychiatry 48:861-73.
32. Miguel-Hidalgo JJ, Rajkowska G. 2002. Morphological brain changes in depression: can antidepressants reverse them? CNS Drugs 16:361-72.
33. Miguel-Hidalgo JJ, Wei J, Overholser JC, Jurjus G, Stockmeier CA, Rajkowska G. 2002. Glial pathology in the prefrontal cortex in alcohol dependence with and without depressive symptoms. Biol Psychiatry 52:1121-33.
34. Nowak G, Ordway GA, Paul IA. 1995. Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res 675:157-64.
35. Ongur D, Drevets WC, Price JL. 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A 95:13290-5.
36. Ordway GA, Klimek V, Mann JJ. 2002. Neurocircuitry of mood disorders. In: David KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifth generation of progress: American College of Neuropsychopharmacology, p 105-144.
37. Orlovskaya DD, Vostrikov VM, Rachmanova NA, Uranova NA. 2000. Decreased numerical density of oligodendroglial cells in postmortem prefrontal cortex in schizophrenia, bipolar affective disorder and major depression. Schizophrenia Res 41:105.
38. Rajkowska G. 2000. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry 48:766-77.
39. Rajkowska G. 2002. Cell pathology in bipolar disorder. Bipolar Disord 4:105-16.
40. Rajkowska G, Goldman-Rakic PS. 1995. Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46. Cereb Cortex 4:323-37.
41. Rajkowska G, Halaris A, Selemon LD. 2001. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 49:741-52.
42. Rajkowska G, Miguel-Hidalgo JJ, Wei J, Dilley G, Pittman SD, Meltzer HY, and others. 1999. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psychiatry 45:1085-98.
43. Rajkowska G, O'Dwyer G, Shao Q, Stockmeier CA, Miguel-Hidalgo JJ. 2002. Calbindin immunoreactive non-pyramidal neurons are reduced in the dorsolateral prefrontal cortex in major depression and schizophrenia [CD-ROM]. Program No. 497.20. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience.
44. Rajkowska G, Selemon LD, Goldman-Rakic PS. 1998. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 55:215-24.
45. Reynolds GP, Zhang ZJ, Patten I, Beasley CL. 2000. Selective deficits of frontal cortical gabaergic neuronal subtypes defined by calcium binding proteins in psychotic ilness. Schizophr Res 41:255.
46. Rocha E, Achaval M, Santos P, Rodnight R. 1998. Lithium treatment causes gliosis and modifies the morphology of hippocampal astrocytes in rats. Neuroreport 9:3971-4.
47. Rosoklija G, Toomayan G, Ellis SP, Keilp J, Mann JJ, Latov N, and others. 2000. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 57:349-56.
48. Sanacora G, Mason GF, Krystal JH. 2000. Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 14:23-45.
49. Sapolsky RM. 2000. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48:755-65.
50. Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, and others. 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174-80.
51. Selemon LD. 2001. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophr Bull 27:349-77.
52. Selemon LD, Rajkowska G, Goldman-Rakic PS. 1995. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 52:805-18.
53. Sheline YI, Sanghavi M, Mintun MA, Gado MH. 1999. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19:5034-43.
54. Stockmeier CA, Jurjus G. 2002. Monoamine receptors in postmortem brain: do postmortem brain studies cloud of clarify our understanding of the affective disorders. In: Agam G, Everall IP, Belmaker RH, editors. The postmortem brain in psychiatric research. Boston: Kluwer Academic. p 363.
55. Stockmeier CA, Mahajan GJ, Konick L, Overholser JC, Jurjus G, Meltzer HY, and others. 2002a. Preliminary evidence that neuronal and glial density is increased and neuronal size is decreased in hippocampus in major depressive disorder (MDD) [CD-ROM]. Program No. 497.19. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience.
56. Stockmeier CA, Shi X, Konick L, Overholser JC, Jurjus G, Meltzer HY, and others. 2002b. Neurokinin-1 receptors are decreased in major depressive disorder. Neuroreport 13:1223-7.
57. Super H, Soriano E, Uylings HB. 1998. The functions of the preplate in development and evolution of the neocortex and hippocampus. Brain Res Brain Res Rev 27:40-64.
58. Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, and others. 2001. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55:597-610.
59. Uylings HB, Sanz Arigita E, de Vos K, Smeets WJ, Pool CW, Amunts K, and others. 2000. The importance of a human 3D database and atlas for studies of prefrontal and thalamic functions. Prog Brain Res 126:357-68.
60. Vawter MP, Freed WJ, Kleinman JE. 2000. Neuropathology of bipolar disorder. Biol Psychiatry 48:486-504.